Science Explorer Back to mapMap

Most cited papers from Eureka Therapeutics (United States)

What are the most cited papers from Eureka Therapeutics (United States)?

The most cited paper from Eureka Therapeutics (United States) is "Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo" (Sarwish Rafiq, Oladapo Yeku, Hollie J. Jackson et al., 2018), with 852 citations. Next come "GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells" (395) and "Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer" (233).

Showing 50 of 71 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo Sarwish Rafiq, Oladapo Yeku, Hollie J. Jackson et al. · Nature Biotechnology Open access 13 Aug 2018 852
2 GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells Eric L. Smith et al. · Science Translational Medicine Open access 27 Mar 2019 395
3 Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer Hong Liu et al. · Clinical Cancer Research 17 Aug 2016 233
4 A membrane-associated MHC-I inhibitory axis for cancer immune evasion Xufeng Chen et al. · Cell Open access Aug 2023 209
5 Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody Tao Dao, Su Yan, Nicholas J. Veomett et al. · Science Translational Medicine Open access 13 Mar 2013 184
6 MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits Hong Liu, Derek C. Radisky, Dun Yang et al. · Nature Cell Biology Open access 13 May 2012 180
7 Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1 Tao Dao, Dmitry Pankov, Andrew Scott et al. · Nature Biotechnology Open access 21 Sep 2015 164
8 Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen Sarwish Rafiq, Terence J. Purdon, Anthony F. Daniyan et al. · Leukemia Open access 7 Dec 2016 156
9 Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies Stephanie M. Salabarria, Manuela Corti, Kirsten E. Coleman et al. · Journal of Clinical Investigation Open access 21 Nov 2023 147
10 Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector Eric L. Smith, Mette Stæhr, Reed Masakayan et al. · Molecular Therapy Open access 28 Mar 2018 127
11 A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release Yiyang Xu, Zhiyuan Yang, Lucas H. Horan et al. · Cell Discovery Open access 14 Nov 2018 122
12 A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens Aaron Y. Chang, Tao Dao, Ron S. Gejman et al. · Journal of Clinical Investigation Open access 18 Jun 2017 95
13 ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy Guilly Rebagay, Su Yan, Cheng Liu et al. · Frontiers in Oncology Open access 2012 79
14 Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics Niloufar Ataie, Jingyi Xiang, Neal N. Cheng et al. · Journal of Molecular Biology Open access 16 Dec 2015 74
15 A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias Leonid Dubrovsky, Dmitry Pankov, Elliott Joseph Brea et al. · Blood Open access 11 Apr 2014 52
16 Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein Nicholas J. Veomett, Tao Dao, Hong Liu et al. · Clinical Cancer Research Open access 21 May 2014 50
17 TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies Mahiuddin Ahmed, Andrés López‐Albaitero, Dmitry Pankov et al. · JCI Insight Open access 21 Feb 2018 49
18 Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth Thapi Dharma Rao, Alberto Fernández‐Tejada, Abram J. Axelrod et al. · ACS Chemical Biology Open access 15 Jun 2017 40
19 Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1 Sung Soo Mun, Jeremy Meyerberg, Leila Peraro et al. · Cancer Immunology Immunotherapy Open access 27 Aug 2023 38
20 Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition Oladapo Yeku, Thapi Dharma Rao, Ian Laster et al. · Frontiers in Immunology Open access 14 Apr 2021 38
21 Novel CD19-specific γ/δ TCR-T cells in relapsed or refractory diffuse large B-cell lymphoma Chenggong Li et al. · Journal of Hematology & Oncology Open access 21 Jan 2023 29
22 A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML Tao Dao, Guangyan Xiong, Sung Soo Mun et al. · Blood Open access 4 Dec 2023 27
23 Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody Tao Dao, Sung Soo Mun, Andrew Scott et al. · OncoImmunology Open access 15 Apr 2019 25
24 A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies Martin G. Klatt, Tao Dao, Zhiyuan Yang et al. · Blood Open access 15 Apr 2022 23
25 Optimizing human α-galactosidase for treatment of Fabry disease William Casey Hallows, Kristen J. Skvorak, Nick Agard et al. · Scientific Reports Open access 23 Mar 2023 19
26 Validation and promise of a TCR mimic antibody for cancer immunotherapy of hepatocellular carcinoma Chang Liu et al. · Scientific Reports Open access 15 Jul 2022 19
27 Directed Evolution of AAV Targeting Primate Retina by Intravitreal Injection Identifies R100, a Variant Demonstrating Robust Gene Delivery and Therapeutic Efficacy in Non-Human Primates Melissa A. Kotterman, Ghezal Beliakoff, Roxanne H. Croze et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 25 Jun 2021 19
28 A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma Pengcheng He, Haibo Liu, Bryan Zimdahl et al. · Journal of Cancer Research and Clinical Oncology Open access Jul 2022 17
29 Intranasal administration of SARS-CoV-2 neutralizing human antibody prevents infection in mice Hongbing Zhang, Zhiyuan Yang, Jingyi Xiang et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 9 Dec 2020 16
30 Frontiers and Opportunities: Highlights of the 2nd Annual Conference of the Chinese Antibody Society Hongyu Zhang, Mi Deng, Peng Lin et al. · Antibody Therapeutics Open access Sep 2018 16
31 Real Time Assays for Quantifying Cytotoxicity with Single Cell Resolution Sonny C. Hsiao, Hong Liu, Taylor A. Holstlaw et al. · PLoS ONE Open access 24 Jun 2013 15
32 Adeno-associated virus-based gene therapy for hemophilia–addressing the gaps Wolfgang Miesbach, Paul A Batty, Pratima Chowdary et al. · Research and Practice in Thrombosis and Haemostasis Open access 31 Dec 2024 13
33 Batch‐to‐Batch and Within‐Subject Variability: What Do We Know and How Do These Variabilities Affect Clinical Pharmacology and Bioequivalence? Leslie Z. Benet, Priya Jayachandran, Kevin J. Carroll et al. · Clinical Pharmacology & Therapeutics Open access 16 Jan 2019 13
34 CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes Melissa Divya Mathias, Jonathan T. Sockolosky, Aaron Y. Chang et al. · Leukemia Open access 12 Jul 2017 13
35 Engineered T Cell Receptor-Mimic Antibody, (TCRm) Chimeric Antigen Receptor (CAR) T Cells Against the Intracellular Protein Wilms Tumor-1 (WT1) for Treatment of Hematologic and Solid Cancers Sarwish Rafiq, Tao Dao, Liu C et al. · Blood 6 Dec 2014 11
36 Development of JCARH125: Optimization of a Fully Human Anti-Bcma CAR for Use in the Treatment of Multiple Myeloma Kim Harrington et al. · University of Southern Denmark Research Portal (University of Southern Denmark) 7 Dec 2017 10
37 Design and characterization of 4D-710, an aerosolized gene therapy for cystic fibrosis lung disease Melissa A. Calton et al. · American Journal of Respiratory Cell and Molecular Biology 22 Oct 2025 8
38 A Therapeutic TCR Mimic Monoclonal Antibody for Intracellular PRAME Protein in Leukemias Aaron Y. Chang, Tao Dao, Andrew Scott et al. · Blood 3 Dec 2015 8
39 CRISPR/Cas9-mediated gene deletion efficiently retards the progression of Philadelphia-positive acute lymphoblastic leukemia in a p210 BCR-ABL1T315I mutation mouse model Yuting Tan, Lin Ye, Fei Xie et al. · Haematologica Open access 19 Sep 2019 7
40 Generation of TCR-Like Antibodies Using Phage Display Brian H. Santich, Hong Liu, Liu C et al. · Methods in molecular biology Book chapter 2015 7
41 Production of a recombinant monoclonal antibody to Herpes Simplex Virus glycoprotein D for immunoaffinity purification of tagged proteins Sara M. O’Rourke, Bin Yu, Javier F. Morales et al. · Journal of Immunological Methods Open access 28 Nov 2018 6
42 Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity Leonid Dubrovsky, Elliott Joseph Brea, Dmitry Pankov et al. · OncoImmunology Open access 3 Aug 2016 6
43 Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation Brandon E. Nemieboka, Sai Kiran Sharma, Thapi Dharma Rao et al. · Nuclear Medicine and Biology Open access May 2020 5
44 A Bi-Specific T Cell Engaging Monoclonal Antibody (mAb) Derived From a TCR-Like Mab Specific For WT1/HLA-A0201 (ESK-BiTE) Shows a Potent Activity Against Human AML and Ph+ ALL In Mouse Models Dmitry Pankov, Tao Dao, Yiyang Wang et al. · Blood 15 Nov 2013 5
45 Assessment of Immune Responses Against AAV Encoded Transgene Products Boris Gorovits et al. · The AAPS Journal 5 Jan 2026 4
46 Real-time Cytotoxicity Assays in Human Whole Blood Ching-Wen Hsiao, Yen-Ting Lo, Hong Liu et al. · Journal of Visualized Experiments Open access 7 Nov 2014 2
47 High-avidity cathepsin-G–specific CAR T cells for the treatment of acute myeloid leukemia Tara A. Walhart et al. · Blood 20 Aug 2026 1
48 IL-12-engineered human PSMA-CAR T cells for the treatment of advanced prostate cancer Lupita S. Lopez, Ziyou Cui, Yukiko Yamaguchi et al. · Molecular Therapy Advances Open access 3 Apr 2026 1
49 Trispecific targeting of T cells engineered with TCR mimic antibodies to limit antigen escape Tao Dao, Guangyan Xiong, Jeremy Meyerberg et al. · Journal for ImmunoTherapy of Cancer Open access 2026 1
50 Antibody-gamma/delta T cell receptors targeting GPC2 regress neuroblastoma with low antigen density Alex Quan, Mingyu Huo, Dan Li et al. · Cell Reports Medicine Open access Oct 2025 1

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.